LONDON (Reuters) – Shares in drugmaker AstraZeneca have climbed more than 7 percent this week, fueled by speculation of renewed takeover interest from Pfizer, following an abortive $118 billion (71 billion pounds) takeover attempt in May.
But while British takeover rules mean deal talks could be back on the cards as early as Aug. 26, following the ending of the first of a two-stage cooling-off period, many investors and analysts see the year-end as a more likely time for any return.
LONDON (Reuters) – Far from wiping out Neanderthals overnight, modern humans rubbed along with their shorter and stockier cousins for thousands of years, giving plenty of time for the two groups to share ideas – and have sex.
The most accurate timeline yet for the demise of our closest relatives, published on Wednesday, shows Neanderthals overlapped with present-day humans in Europe for between 2,600 and 5,400 years before disappearing about 40,000 years ago.
LONDON (Reuters) – Up to 30,000 people could have used experimental treatments or vaccines so far in the world’s worst outbreak of Ebola currently plaguing West Africa, British scientists said on Wednesday.
The calculation highlights the dilemma facing officials considering how to distribute the tiny quantities of unproven drugs that are likely to be available in the near term to fight the deadly disease.